Table 1 Demographic and treatment characteristics (n = 20)
Current age (years) | 17 (8–24) |
|---|---|
Age at diagnosis (years) | 13 (6–21) |
Time since diagnosis (years) | 4.4 (0.5–15.3) |
Peak VO2 (L/min) | 1.9 ± 0.9 |
% Predicted peak VO2 (%) | 81 ± 20 |
Haemoglobin, g/L | 129 (93, 184) |
Sex | |
 Male | 10 (50%) |
 Female | 10 (50%) |
Diagnosis | |
 Acute lymphoblastic leukaemia | 12 (60%) |
 Acute myeloid leukaemia | 5 (25%) |
 Hodgkin rumour | 2 (10%) |
 Wilms rumour | 1 (5%) |
Treatment Details | |
 Anthracycline, cumulative dose exposure (mg/m2) | 175 (89–670) |
 Chest-targeted radiation | 2 (10%) |
 Craniospinal radiation | 2 (10%) |
 Total body radiation | 2 (10%) |
 Allogeneic SCT | 2 (10%) |
Cardiovascular risk factors | |
 Hypertension | 1 (5%) |
 Diabetes | 2 (10%) |
 Dyslipidaemia | 3 (15%) |
 Chronic renal insufficiency | 1 (5%) |
 BMI > 25 kg/m2 | 3 (15%) |